Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
B-Lymphocytes | 36 | 2022 | 724 | 3.180 |
Why?
|
Lymphopoiesis | 12 | 2022 | 48 | 2.840 |
Why?
|
Bone Marrow Cells | 22 | 2021 | 253 | 2.220 |
Why?
|
Precursor Cells, B-Lymphoid | 5 | 2016 | 27 | 1.990 |
Why?
|
Hematopoietic Stem Cells | 23 | 2022 | 292 | 1.950 |
Why?
|
fms-Like Tyrosine Kinase 3 | 8 | 2022 | 127 | 1.860 |
Why?
|
Cell Lineage | 22 | 2016 | 273 | 1.800 |
Why?
|
Cell Differentiation | 25 | 2022 | 1458 | 1.410 |
Why?
|
Homeodomain Proteins | 8 | 2016 | 536 | 1.390 |
Why?
|
Multipotent Stem Cells | 3 | 2014 | 19 | 1.030 |
Why?
|
Lymphoid Progenitor Cells | 3 | 2013 | 16 | 0.970 |
Why?
|
Flow Cytometry | 6 | 2021 | 679 | 0.940 |
Why?
|
Immunity, Humoral | 1 | 2022 | 67 | 0.830 |
Why?
|
Dendritic Cells | 3 | 2013 | 425 | 0.810 |
Why?
|
Hematopoiesis | 15 | 2016 | 163 | 0.770 |
Why?
|
Bone Marrow | 11 | 2018 | 435 | 0.760 |
Why?
|
Transcription Factors | 8 | 2021 | 1565 | 0.740 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2018 | 136 | 0.700 |
Why?
|
Mice | 49 | 2022 | 11352 | 0.670 |
Why?
|
Killer Cells, Natural | 3 | 2018 | 267 | 0.640 |
Why?
|
Mice, Knockout | 11 | 2016 | 1924 | 0.590 |
Why?
|
Proto-Oncogene Proteins c-pim-1 | 1 | 2016 | 10 | 0.570 |
Why?
|
Estrogens | 6 | 2013 | 200 | 0.570 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2016 | 5 | 0.560 |
Why?
|
Animals | 57 | 2022 | 26582 | 0.560 |
Why?
|
Mice, Inbred C57BL | 14 | 2016 | 3092 | 0.530 |
Why?
|
Cell Proliferation | 5 | 2021 | 1578 | 0.520 |
Why?
|
Immune System | 1 | 2016 | 93 | 0.510 |
Why?
|
Trans-Activators | 7 | 2018 | 429 | 0.470 |
Why?
|
B-Lymphocyte Subsets | 4 | 2010 | 40 | 0.470 |
Why?
|
Signal Transduction | 8 | 2014 | 3241 | 0.400 |
Why?
|
Antigens, CD | 8 | 2013 | 458 | 0.390 |
Why?
|
Cell Survival | 6 | 2016 | 969 | 0.370 |
Why?
|
Gene Expression Regulation, Developmental | 5 | 2008 | 623 | 0.360 |
Why?
|
Transcription, Genetic | 5 | 2013 | 1135 | 0.360 |
Why?
|
Genes, Immunoglobulin | 4 | 2005 | 111 | 0.360 |
Why?
|
Cells, Cultured | 13 | 2021 | 2818 | 0.350 |
Why?
|
Membrane Proteins | 5 | 2013 | 1196 | 0.340 |
Why?
|
Lymphocytes | 6 | 2005 | 464 | 0.330 |
Why?
|
Mice, Transgenic | 9 | 2021 | 1540 | 0.330 |
Why?
|
Receptors, Interleukin-7 | 4 | 2013 | 28 | 0.310 |
Why?
|
Proto-Oncogene Proteins | 5 | 2018 | 645 | 0.290 |
Why?
|
Antigens, CD34 | 2 | 2018 | 158 | 0.270 |
Why?
|
Pregnancy, Animal | 3 | 1994 | 58 | 0.270 |
Why?
|
Apoptosis | 3 | 2011 | 1683 | 0.260 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 2 | 2005 | 37 | 0.260 |
Why?
|
DNA-Binding Proteins | 9 | 2008 | 1208 | 0.250 |
Why?
|
Transgenes | 2 | 2016 | 180 | 0.250 |
Why?
|
Antigens, Ly | 2 | 2013 | 37 | 0.240 |
Why?
|
Interleukin-7 | 6 | 2007 | 41 | 0.210 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2021 | 10 | 0.210 |
Why?
|
Immunoglobulin Class Switching | 1 | 2021 | 37 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2014 | 189 | 0.200 |
Why?
|
Ligands | 1 | 2022 | 433 | 0.190 |
Why?
|
Stem Cells | 4 | 2014 | 351 | 0.190 |
Why?
|
Mice, Inbred BALB C | 13 | 2003 | 1047 | 0.180 |
Why?
|
Antigens, CD19 | 3 | 2013 | 39 | 0.180 |
Why?
|
Leukocyte Common Antigens | 3 | 2013 | 46 | 0.180 |
Why?
|
Gene Expression Regulation | 2 | 2005 | 1920 | 0.170 |
Why?
|
GATA2 Transcription Factor | 1 | 2018 | 14 | 0.170 |
Why?
|
GATA1 Transcription Factor | 1 | 2018 | 18 | 0.170 |
Why?
|
Cellular Senescence | 2 | 2016 | 94 | 0.150 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 151 | 0.150 |
Why?
|
Membrane Glycoproteins | 5 | 2013 | 428 | 0.150 |
Why?
|
Satellite Cells, Skeletal Muscle | 1 | 2016 | 2 | 0.150 |
Why?
|
GPI-Linked Proteins | 2 | 2013 | 50 | 0.150 |
Why?
|
Growth and Development | 1 | 2016 | 12 | 0.150 |
Why?
|
Lymphocyte Count | 2 | 2013 | 94 | 0.140 |
Why?
|
Epistasis, Genetic | 1 | 2016 | 86 | 0.140 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 683 | 0.130 |
Why?
|
Stress, Physiological | 1 | 2016 | 227 | 0.130 |
Why?
|
Humans | 20 | 2021 | 86643 | 0.120 |
Why?
|
Progesterone | 1 | 1994 | 110 | 0.120 |
Why?
|
CD11c Antigen | 1 | 2013 | 11 | 0.120 |
Why?
|
Janus Kinase 2 | 1 | 2014 | 57 | 0.120 |
Why?
|
Gene Rearrangement | 3 | 2005 | 170 | 0.120 |
Why?
|
Granulocyte-Macrophage Progenitor Cells | 1 | 2013 | 1 | 0.120 |
Why?
|
Signaling Lymphocytic Activation Molecule Family Member 1 | 1 | 2013 | 4 | 0.120 |
Why?
|
Platelet Membrane Glycoprotein IIb | 1 | 2013 | 5 | 0.120 |
Why?
|
Receptors, Complement | 1 | 2013 | 46 | 0.120 |
Why?
|
PAX5 Transcription Factor | 4 | 2008 | 32 | 0.120 |
Why?
|
Gene Expression | 6 | 2012 | 1284 | 0.110 |
Why?
|
Models, Immunological | 1 | 2013 | 80 | 0.110 |
Why?
|
Repressor Proteins | 2 | 2008 | 403 | 0.110 |
Why?
|
Arthritis | 1 | 2012 | 46 | 0.110 |
Why?
|
B7-2 Antigen | 1 | 2012 | 40 | 0.110 |
Why?
|
Stromal Cells | 6 | 2003 | 143 | 0.110 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2003 | 179 | 0.100 |
Why?
|
Receptors, Cell Surface | 1 | 2013 | 286 | 0.100 |
Why?
|
Adipocytes | 2 | 2003 | 155 | 0.100 |
Why?
|
Lymphocyte Subsets | 3 | 2013 | 64 | 0.100 |
Why?
|
Female | 18 | 2021 | 44532 | 0.100 |
Why?
|
Inhibitor of Differentiation Protein 1 | 1 | 2011 | 8 | 0.100 |
Why?
|
Male | 15 | 2021 | 40965 | 0.100 |
Why?
|
Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2011 | 35 | 0.100 |
Why?
|
Gonadal Steroid Hormones | 4 | 2012 | 50 | 0.100 |
Why?
|
Cell Line | 6 | 2010 | 2468 | 0.100 |
Why?
|
Immune Tolerance | 1 | 1993 | 337 | 0.100 |
Why?
|
Homeostasis | 1 | 2013 | 409 | 0.100 |
Why?
|
Cell Count | 1 | 2011 | 195 | 0.100 |
Why?
|
Aged, 80 and over | 3 | 2018 | 6509 | 0.100 |
Why?
|
Co-Repressor Proteins | 1 | 2010 | 18 | 0.090 |
Why?
|
Haploinsufficiency | 1 | 2011 | 62 | 0.090 |
Why?
|
Testosterone Propionate | 1 | 2010 | 1 | 0.090 |
Why?
|
Adult Stem Cells | 1 | 2010 | 30 | 0.090 |
Why?
|
Periaqueductal Gray | 1 | 2010 | 10 | 0.090 |
Why?
|
Gene Silencing | 1 | 2010 | 172 | 0.090 |
Why?
|
Heterozygote | 1 | 2011 | 365 | 0.090 |
Why?
|
Immunoglobulin Variable Region | 3 | 2005 | 109 | 0.090 |
Why?
|
Spleen | 4 | 2021 | 430 | 0.090 |
Why?
|
Narcotics | 1 | 2010 | 69 | 0.090 |
Why?
|
Mice, Mutant Strains | 3 | 2004 | 229 | 0.090 |
Why?
|
Androgens | 1 | 2010 | 167 | 0.090 |
Why?
|
Proteins | 3 | 2005 | 777 | 0.090 |
Why?
|
Morphine | 1 | 2010 | 130 | 0.090 |
Why?
|
Lymphocyte Activation | 2 | 2009 | 728 | 0.080 |
Why?
|
RNA, Messenger | 8 | 2010 | 1981 | 0.080 |
Why?
|
Pregnancy | 7 | 2010 | 2894 | 0.080 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2005 | 131 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2005 | 879 | 0.070 |
Why?
|
Cell Division | 5 | 2002 | 696 | 0.070 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 2 | 2003 | 37 | 0.070 |
Why?
|
Receptors, Antigen, B-Cell | 2 | 2004 | 113 | 0.070 |
Why?
|
Milk Proteins | 1 | 2005 | 24 | 0.070 |
Why?
|
Genes, Regulator | 1 | 2005 | 65 | 0.060 |
Why?
|
Genetic Complementation Test | 1 | 2004 | 97 | 0.060 |
Why?
|
Thymus Gland | 5 | 2002 | 195 | 0.060 |
Why?
|
Retroviridae | 1 | 2004 | 79 | 0.060 |
Why?
|
Aged | 3 | 2018 | 18415 | 0.060 |
Why?
|
Antibodies, Monoclonal | 4 | 1996 | 1376 | 0.060 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2005 | 153 | 0.060 |
Why?
|
Lymphocyte Depletion | 2 | 1994 | 97 | 0.060 |
Why?
|
Cell Nucleus | 2 | 2005 | 579 | 0.060 |
Why?
|
Myeloid Cells | 3 | 2012 | 98 | 0.060 |
Why?
|
Dexamethasone | 1 | 2005 | 326 | 0.060 |
Why?
|
Cytokines | 3 | 2000 | 776 | 0.060 |
Why?
|
Chromatin | 3 | 2016 | 380 | 0.060 |
Why?
|
Fluorescent Antibody Technique | 3 | 2000 | 316 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2005 | 352 | 0.050 |
Why?
|
Leukopoiesis | 1 | 2002 | 3 | 0.050 |
Why?
|
Middle Aged | 3 | 2018 | 25028 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2005 | 339 | 0.050 |
Why?
|
Dinoprostone | 1 | 2002 | 69 | 0.050 |
Why?
|
Sulfur | 1 | 2021 | 28 | 0.050 |
Why?
|
T-Lymphocytes | 2 | 2002 | 1195 | 0.050 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2001 | 17 | 0.050 |
Why?
|
Binding Sites | 1 | 2004 | 1098 | 0.050 |
Why?
|
Iron | 1 | 2021 | 164 | 0.050 |
Why?
|
Tumor Cells, Cultured | 4 | 2009 | 1041 | 0.050 |
Why?
|
Bone Development | 1 | 2000 | 34 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2012 | 878 | 0.050 |
Why?
|
Adult | 2 | 2018 | 25648 | 0.050 |
Why?
|
Leukosialin | 1 | 2000 | 16 | 0.050 |
Why?
|
Mutagenesis, Insertional | 1 | 2000 | 111 | 0.050 |
Why?
|
Bromodeoxyuridine | 1 | 2000 | 57 | 0.050 |
Why?
|
Sialoglycoproteins | 1 | 2000 | 31 | 0.050 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2000 | 95 | 0.040 |
Why?
|
DNA Damage | 1 | 2021 | 366 | 0.040 |
Why?
|
Promoter Regions, Genetic | 3 | 2010 | 937 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 1999 | 79 | 0.040 |
Why?
|
Colony-Forming Units Assay | 2 | 2000 | 40 | 0.040 |
Why?
|
Adipose Tissue | 2 | 1992 | 240 | 0.040 |
Why?
|
Animals, Newborn | 2 | 2010 | 510 | 0.040 |
Why?
|
Oncogenes | 1 | 1998 | 88 | 0.040 |
Why?
|
Mitochondria | 1 | 2021 | 535 | 0.040 |
Why?
|
Sex Factors | 2 | 2012 | 1054 | 0.040 |
Why?
|
Steroids | 2 | 2013 | 177 | 0.040 |
Why?
|
Radiation Chimera | 2 | 2010 | 23 | 0.040 |
Why?
|
Coculture Techniques | 2 | 2009 | 164 | 0.040 |
Why?
|
Connective Tissue | 1 | 1996 | 23 | 0.040 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2001 | 567 | 0.030 |
Why?
|
Immunophenotyping | 2 | 2009 | 211 | 0.030 |
Why?
|
Regeneration | 1 | 2016 | 143 | 0.030 |
Why?
|
Lipoprotein Lipase | 2 | 1992 | 14 | 0.030 |
Why?
|
Enzyme Activation | 2 | 2009 | 692 | 0.030 |
Why?
|
Integrins | 1 | 1994 | 76 | 0.030 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 3 | 2001 | 19 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2016 | 449 | 0.030 |
Why?
|
Rats | 4 | 2010 | 3990 | 0.030 |
Why?
|
Adiponectin | 2 | 2003 | 24 | 0.030 |
Why?
|
Mice, Inbred NOD | 2 | 2005 | 187 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2005 | 348 | 0.030 |
Why?
|
Lymphoid Tissue | 1 | 1993 | 57 | 0.030 |
Why?
|
Estradiol | 1 | 1993 | 252 | 0.030 |
Why?
|
Testosterone | 1 | 1994 | 271 | 0.030 |
Why?
|
Arthritis, Experimental | 1 | 2012 | 24 | 0.030 |
Why?
|
Growth Inhibitors | 2 | 2003 | 41 | 0.030 |
Why?
|
Aging | 1 | 2016 | 691 | 0.030 |
Why?
|
Age Factors | 2 | 2010 | 1851 | 0.030 |
Why?
|
Fetal Blood | 2 | 2002 | 90 | 0.030 |
Why?
|
Recombination, Genetic | 2 | 2005 | 439 | 0.030 |
Why?
|
Mice, SCID | 2 | 2002 | 252 | 0.030 |
Why?
|
Cell Line, Transformed | 2 | 2002 | 154 | 0.020 |
Why?
|
HLA Antigens | 1 | 2012 | 232 | 0.020 |
Why?
|
Phenotype | 2 | 2012 | 2378 | 0.020 |
Why?
|
Interferon-gamma | 1 | 1993 | 444 | 0.020 |
Why?
|
Transplantation, Heterologous | 2 | 2002 | 363 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 1991 | 163 | 0.020 |
Why?
|
Environment | 1 | 2012 | 219 | 0.020 |
Why?
|
Models, Biological | 3 | 2005 | 1749 | 0.020 |
Why?
|
Castration | 1 | 2010 | 41 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 74 | 0.020 |
Why?
|
Molecular Sequence Data | 4 | 2000 | 3030 | 0.020 |
Why?
|
Antigens, Surface | 1 | 1990 | 101 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2005 | 927 | 0.020 |
Why?
|
Receptors, Transferrin | 1 | 2009 | 10 | 0.020 |
Why?
|
Antigens, Differentiation | 1 | 1990 | 141 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 1992 | 503 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 115 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2010 | 347 | 0.020 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 1989 | 47 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 1992 | 532 | 0.020 |
Why?
|
Reaction Time | 1 | 2010 | 309 | 0.020 |
Why?
|
Cell Communication | 1 | 2009 | 194 | 0.020 |
Why?
|
Pain Measurement | 1 | 2010 | 321 | 0.020 |
Why?
|
Clone Cells | 3 | 1995 | 213 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2008 | 5 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 322 | 0.020 |
Why?
|
Amino Acid Sequence | 3 | 2000 | 2062 | 0.020 |
Why?
|
DNA, Complementary | 2 | 2000 | 393 | 0.020 |
Why?
|
Immunoglobulin Light Chains | 2 | 2002 | 86 | 0.020 |
Why?
|
Cell Adhesion | 3 | 1996 | 420 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2010 | 1219 | 0.020 |
Why?
|
NF-kappa B | 1 | 2010 | 444 | 0.020 |
Why?
|
Up-Regulation | 1 | 2009 | 712 | 0.020 |
Why?
|
Immunoglobulin mu-Chains | 2 | 2000 | 18 | 0.020 |
Why?
|
Down-Regulation | 1 | 2008 | 504 | 0.020 |
Why?
|
Octamer Transcription Factor-1 | 1 | 2005 | 17 | 0.020 |
Why?
|
STAT5 Transcription Factor | 1 | 2005 | 42 | 0.020 |
Why?
|
Polycomb Repressive Complex 2 | 1 | 2005 | 30 | 0.020 |
Why?
|
Enhancer of Zeste Homolog 2 Protein | 1 | 2005 | 35 | 0.020 |
Why?
|
Receptors, Cytokine | 1 | 2005 | 28 | 0.020 |
Why?
|
Genes, bcl-2 | 1 | 2005 | 16 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2005 | 134 | 0.020 |
Why?
|
Hormone Antagonists | 1 | 2005 | 20 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2005 | 133 | 0.020 |
Why?
|
Mifepristone | 1 | 2005 | 33 | 0.020 |
Why?
|
Dealkylation | 1 | 2004 | 3 | 0.020 |
Why?
|
Oligonucleotides | 1 | 2005 | 92 | 0.020 |
Why?
|
CD79 Antigens | 1 | 2004 | 17 | 0.020 |
Why?
|
Disease Progression | 1 | 2009 | 1531 | 0.020 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2004 | 52 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2005 | 154 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2009 | 1939 | 0.020 |
Why?
|
Myelopoiesis | 1 | 2003 | 10 | 0.020 |
Why?
|
Prostaglandins | 1 | 2003 | 43 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 425 | 0.010 |
Why?
|
Pre-B Cell Receptors | 1 | 2003 | 8 | 0.010 |
Why?
|
Histones | 1 | 2005 | 311 | 0.010 |
Why?
|
Antigens, CD7 | 1 | 2002 | 2 | 0.010 |
Why?
|
Interferon Regulatory Factors | 1 | 2003 | 67 | 0.010 |
Why?
|
Neprilysin | 1 | 2002 | 42 | 0.010 |
Why?
|
Precipitin Tests | 2 | 1994 | 108 | 0.010 |
Why?
|
Centromere | 1 | 2002 | 26 | 0.010 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2002 | 40 | 0.010 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2002 | 33 | 0.010 |
Why?
|
Heterochromatin | 1 | 2002 | 22 | 0.010 |
Why?
|
3T3 Cells | 1 | 2002 | 94 | 0.010 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2002 | 42 | 0.010 |
Why?
|
Hormones | 1 | 2002 | 141 | 0.010 |
Why?
|
Paracrine Communication | 1 | 2002 | 31 | 0.010 |
Why?
|
Nuclear Envelope | 1 | 2002 | 36 | 0.010 |
Why?
|
Thiophenes | 1 | 2002 | 48 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2002 | 100 | 0.010 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2002 | 96 | 0.010 |
Why?
|
CD5 Antigens | 1 | 2001 | 14 | 0.010 |
Why?
|
Adipose Tissue, Brown | 1 | 2002 | 80 | 0.010 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2001 | 20 | 0.010 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2001 | 74 | 0.010 |
Why?
|
Complement Factor D | 2 | 1992 | 3 | 0.010 |
Why?
|
Macrophage Colony-Stimulating Factor | 2 | 1992 | 18 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2003 | 378 | 0.010 |
Why?
|
Isoenzymes | 1 | 2002 | 271 | 0.010 |
Why?
|
Kyphosis | 1 | 2000 | 14 | 0.010 |
Why?
|
Fluoresceins | 1 | 2000 | 43 | 0.010 |
Why?
|
Serine Endopeptidases | 2 | 1992 | 145 | 0.010 |
Why?
|
Tibia | 1 | 2000 | 82 | 0.010 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2000 | 19 | 0.010 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2000 | 20 | 0.010 |
Why?
|
Receptors, Interferon | 1 | 2000 | 31 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2000 | 307 | 0.010 |
Why?
|
Models, Animal | 1 | 2001 | 263 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2002 | 1014 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 2000 | 148 | 0.010 |
Why?
|
DNA Nucleotidylexotransferase | 1 | 1999 | 11 | 0.010 |
Why?
|
Bone Density | 1 | 2000 | 209 | 0.010 |
Why?
|
Cell Cycle | 1 | 2001 | 502 | 0.010 |
Why?
|
Interferon Type I | 1 | 2000 | 175 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2000 | 646 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2000 | 254 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 2000 | 272 | 0.010 |
Why?
|
Radiography | 1 | 2000 | 813 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 1998 | 72 | 0.010 |
Why?
|
Heparan Sulfate Proteoglycans | 1 | 1998 | 21 | 0.010 |
Why?
|
Hyaluronan Receptors | 1 | 1998 | 36 | 0.010 |
Why?
|
Graft Survival | 1 | 2001 | 884 | 0.010 |
Why?
|
Depression, Chemical | 1 | 1996 | 29 | 0.010 |
Why?
|
Antigen-Antibody Reactions | 1 | 1996 | 23 | 0.010 |
Why?
|
Base Sequence | 1 | 2000 | 2330 | 0.010 |
Why?
|
Gene Library | 1 | 1996 | 130 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2001 | 1384 | 0.010 |
Why?
|
Hybridomas | 1 | 1994 | 74 | 0.010 |
Why?
|
Integrin beta1 | 1 | 1994 | 33 | 0.010 |
Why?
|
Antibody Affinity | 1 | 1994 | 38 | 0.010 |
Why?
|
Glycosylation | 1 | 1994 | 129 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1994 | 303 | 0.010 |
Why?
|
Lymphoma | 1 | 1996 | 262 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2000 | 2232 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 1995 | 384 | 0.010 |
Why?
|
Fatty Acid-Binding Protein 7 | 1 | 1992 | 1 | 0.010 |
Why?
|
Biomarkers | 1 | 1999 | 1718 | 0.010 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 1992 | 9 | 0.010 |
Why?
|
Blotting, Western | 1 | 1994 | 782 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 1992 | 34 | 0.010 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 1992 | 26 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1992 | 245 | 0.010 |
Why?
|
Culture Media | 1 | 1992 | 147 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1992 | 256 | 0.010 |
Why?
|
DNA | 1 | 1998 | 1294 | 0.010 |
Why?
|
Receptors, Very Late Antigen | 1 | 1991 | 6 | 0.010 |
Why?
|
Carcinoma, Renal Cell | 1 | 1996 | 426 | 0.010 |
Why?
|
Interleukin-6 | 1 | 1993 | 256 | 0.010 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 1991 | 56 | 0.010 |
Why?
|
Genetic Markers | 1 | 1992 | 476 | 0.010 |
Why?
|
Immunoglobulin Light Chains, Surrogate | 1 | 1991 | 4 | 0.010 |
Why?
|
Proto-Oncogenes | 1 | 1991 | 61 | 0.010 |
Why?
|
Colony-Stimulating Factors | 1 | 1990 | 14 | 0.010 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 1990 | 11 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 1996 | 621 | 0.010 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 1990 | 18 | 0.010 |
Why?
|
Angiotensinogen | 1 | 1990 | 8 | 0.010 |
Why?
|
Histocytochemistry | 1 | 1990 | 130 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 1991 | 140 | 0.010 |
Why?
|
Apolipoproteins E | 1 | 1990 | 129 | 0.010 |
Why?
|
Biological Factors | 1 | 1989 | 18 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 1991 | 269 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1992 | 673 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 1990 | 196 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 1991 | 427 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 1992 | 696 | 0.000 |
Why?
|
Enhancer Elements, Genetic | 1 | 1990 | 266 | 0.000 |
Why?
|
In Vitro Techniques | 1 | 1989 | 989 | 0.000 |
Why?
|
Lymph Nodes | 1 | 1990 | 533 | 0.000 |
Why?
|